Shares of Nuburu (BURU) sit at $0.04 — down roughly 33% in a week — as renewed attention to NYSE American delisting proceedings forces investors to confront whether this defense-tech penny stock has a viable path forward.

On July 17, 2026, NYSE American announced it would commence proceedings to delist Nuburu's common stock, citing Section 1003(f)(v) of its Company Guide due to the stock's low selling price.

The action was triggered after shares traded below $0.10 that day.

Trading was suspended immediately. Nearly a month later, the stock continues to deteriorate — a signal the market sees survival as uncertain regardless of broader tech-sector strength.

  • A Reverse Split Already Failed Once This Year. Nuburu executed a 1-for-4.99 reverse stock split in February 2026 to regain compliance with the exchange's minimum trading price.

The exchange warned that if shares traded below $0.10 again, the stock would be halted and delisted — which is exactly what happened. A second reverse split is planned, but repeating the same tactic that already collapsed inspires little confidence.

  • $38 Million Raised, but the Cash May Be Spoken For. On July 17 Nuburu closed an equity offering raising roughly $38 million in gross proceeds — about $35.6 million net — priced at a 30% premium to the prior close.

The company plans to use proceeds partly to redeem approximately $15.5 million in debt and pay $1.25 million of convertible notes. After debt retirement and acquisition costs, the runway for actual operations shrinks significantly.

  • The Going-Concern Flag Has Not Been Lowered. Nuburu's own filings identify "substantial doubt about its ability to continue as a going concern," citing historical losses, negative operating cash flows, heavy debt obligations, and dependence on outside financing.

Q1 2026 revenue was just $407,644 — essentially a rounding error for a company trying to build a defense-technology platform.

  • Institutional Access Evaporates Below the Exchange Threshold. Delisting would push BURU to the over-the-counter market, where many mutual funds and institutional investors are barred from trading. That effectively cuts off a critical source of future capital at the exact moment the company needs it most. Analyst consensus already rates BURU as "Underperform," reflecting significant financial instability and poor technical indicators.

The math is unforgiving: a four-cent stock, a going-concern warning, and a failed reverse split. Unless Q2 results or the Tekne acquisition deliver a dramatic inflection, Nuburu is running a race against its own balance sheet — and the clock is winning.